What is Benralizumab?

Category: Prescription Drugs

Most popular types: Fasenra

false

Benralizumab is a monoclonal antibody used for the treatment of asthma.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Benralizumab

Side effect Patients Percentage
Constant tiredness 1
Headaches 1
Muscle pain 1
New daily persistent headache 1
Tiredness 1

Dosages

Based on patients currently taking Benralizumab

Dosage Patients Percentage
30 mg monthly 1
30 mg every 3 weeks 1

Duration

Currently taking Benralizumab

Duration Patients Percentage
6 months - 1 year 1
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 0
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Benralizumab.